Association between bilirubin and mode of death in severe systolic heart failure

American Journal of Cardiology

Volumn 111, Issue 8, 2013, Pages 1192-1197

  Wu, Audrey H ^a   Levy, Wayne C ^b   Welch, Kathleen B ^c   Neuberg, Gerald W ^d   O'Connor, Christopher M ^e   Carson, Peter E ^f   Miller, Alan B ^g   Ghali, Jalal K ^h  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d College of Physicians and Surgeons ^*  (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF FLORIDA   (United States)

^h MERCER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BILIRUBIN; FUROSEMIDE; PLACEBO; SODIUM;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE;

AGED; BILIRUBIN; BIOLOGICAL MARKERS; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84875850762     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.12.048     Document Type: Article

References (27)

1. P.A. Poole-Wilson, B.F. Uretsky, K. Thygesen, J.G. Cleland, B.M. Massie, and L. Ryden Mode of death in heart failure: findings from the ATLAS trial Heart 89 2003 42 48
2. M.T. Kearney, K.A. Fox, A.J. Lee, R.J. Prescott, A.M. Shah, P.D. Batin, W. Baig, S. Lindsay, T.S. Callahan, W.E. Shell, D.L. Eckberg, A.G. Zaman, S. Williams, J.M. Neilson, and J. Nolan Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure J Am Coll Cardiol 40 2002 1801 1808
3. P.A. Mehta, S.W. Dubrey, H.F. McIntyre, D.M. Walker, S.M. Hardman, G.C. Sutton, T.A. McDonagh, and M.R. Cowie Mode of death in patients with newly diagnosed heart failure in the general population Eur J Heart Fail 10 2008 1108 1116
4. T. Hofmann, T. Meinertz, W. Kasper, A. Geibel, M. Zehender, S. Hohnloser, U. Stienen, N. Treese, and H. Just Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinants Am Heart J 116 1988 1455 1463
5. S.H. Kubo, B.A. Walter, D.H. John, M. Clark, and R.J. Cody Liver function abnormalities in chronic heart failure: influence of systemic hemodynamics Arch Intern Med 147 1987 1227 1230
6. V.M. van Deursen, K. Damman, H.L. Hillege, A.P. van Beek, D.J. van Veldhuisen, and A.A. Voors Abnormal liver function in relation to hemodynamic profile in heart failure patients J Card Fail 16 2010 84 90
7. H. Shinagawa, T. Inomata, T. Koitabashi, H. Nakano, I. Takeuchi, T. Naruke, T. Ohsaka, M. Nishii, H. Takehana, and T. Izumi Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure Circ J 72 2008 364 369
8. P. Batin, M. Wickens, D. McEntegart, L. Fullwood, and A.J. Cowley The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure Eur Heart J 16 1995 1613 1618
9. L.A. Allen, G.M. Felker, S. Pocock, J.J. McMurray, M.A. Pfeffer, K. Swedberg, D. Wang, S. Yusuf, E.L. Michelson, and C.B. Granger Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program Eur J Heart Fail 11 2009 170 177
10. M. Packer, C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, R.N. Belkin, A.B. Miller, G.W. Neuberg, D. Frid, J.H. Wertheimer, A.B. Cropp, and D.L. DeMets Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group N Engl J Med 335 1996 1107 1114
11. J.M. Satagopan, L. Ben-Porat, M. Berwick, M. Robson, D. Kutler, and A.D. Auerbach A note on competing risks in survival data analysis Br J Cancer 91 2004 1229 1235
12. W.C. Levy, D. Mozaffarian, D.T. Linker, S.C. Sutradhar, S.D. Anker, A.B. Cropp, I. Anand, A. Maggioni, P. Burton, M.D. Sullivan, B. Pitt, P.A. Poole-Wilson, D.L. Mann, and M. Packer The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
13. S. Eshaghian, T.B. Horwich, and G.C. Fonarow Relation of loop diuretic dose to mortality in advanced heart failure Am J Cardiol 97 2006 1759 1764
14. A.P. Ambrosy, M. Vaduganathan, M.D. Huffman, S. Khan, M.J. Kwasny, A.J. Fought, A.P. Maggioni, K. Swedberg, M.A. Konstam, F. Zannad, and M. Gheorghiade Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial Eur J Heart Fail 14 2012 302 311
15. J.C. Matthews, T.M. Koelling, F.D. Pagani, and K.D. Aaronson The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 51 2008 2163 2172
16. J.C. Matthews, F.D. Pagani, J.W. Haft, T.M. Koelling, D.C. Naftel, and K.D. Aaronson Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality Circulation 121 2010 214 220
17. P.N. Hopkins, L.L. Wu, S.C. Hunt, B.C. James, G.M. Vincent, and R.R. Williams Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease Arterioscler Thromb Vasc Biol 16 1996 250 255
18. S.C. Hunt, F. Kronenberg, J.H. Eckfeldt, P.N. Hopkins, R.H. Myers, and G. Heiss Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study Atherosclerosis 154 2001 747 754
19. L.J. Horsfall, G. Rait, K. Walters, D.M. Swallow, S.P. Pereira, I. Nazareth, and I. Petersen Serum bilirubin and risk of respiratory disease and death JAMA 305 2011 691 697
20. L. Djousse, D. Levy, L.A. Cupples, J.C. Evans, R.B. D'Agostino, and R.C. Ellison Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study Am J Cardiol 87 2001 1196 1200 A4, 7
21. T.W. Wu, J. Wu, R.K. Li, D. Mickle, and D. Carey Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage Biochem Cell Biol 69 1991 683 688
22. R. Stocker, A.N. Glazer, and B.N. Ames Antioxidant activity of albumin-bound bilirubin Proc Natl Acad Sci U S A 84 1987 5918 5922
23. M. Ess, C. Mussner-Seeber, S. Mariacher, A. Lorsbach-Koehler, O. Pachinger, M. Frick, H. Ulmer, and G. Poelzl γ-Glutamyltransferase rather than total bilirubin predicts outcome in chronic heart failure J Card Fail 17 2011 577 584
24. S. Bonet, A. Agusti, J.M. Arnau, X. Vidal, E. Diogene, E. Galve, and J.R. Laporte Beta-adrenergic blocking agents in heart failure: benefits of vasodilating and non-vasodilating agents according to patients' characteristics: a meta-analysis of clinical trials Arch Intern Med 160 2000 621 627
25. D.L. Packer, J.M. Prutkin, A.S. Hellkamp, L.B. Mitchell, R.C. Bernstein, F. Wood, J.P. Boehmer, M.D. Carlson, R.P. Frantz, S.E. McNulty, J.G. Rogers, J. Anderson, G.W. Johnson, M.N. Walsh, J.E. Poole, D.B. Mark, K.L. Lee, and G.H. Bardy Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial Circulation 120 2009 2170 2176
26. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, and J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
27. P. Carson, I. Anand, C. O'Connor, B. Jaski, J. Steinberg, A. Lwin, J. Lindenfeld, J. Ghali, J.H. Barnet, A.M. Feldman, and M.R. Bristow Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial J Am Coll Cardiol 46 2005 2329 2334